The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS
Open accessAbstract
The restoration of myelin sheaths on demyelinated axons remains a major obstacle in the treatment of multiple sclerosis (MS). Currently approved therapies work by modulating the immune system to reduce the number and rate of lesion formation but are only partially effective since they are not able to restore lost myelin. In the healthy CNS, myelin continues to be generated throughout life and spontaneous remyelination occurs readily in response to insults. In patients with MS, however, remyelination eventually fails, at least in part as a result of a failure of oligodendrocyte precursor cell (OPC) differentiation and the subsequent production of new myelin. A better understanding of the molecular mechanisms and signaling pathways that drive the process of myelin sheath formation is therefore important in order to speed the development of novel therapeutics designed to target remyelination. Here we review data supporting critical roles for three highly conserved intracellular signaling pathways: Wnt/β-catenin, PI3K/AKT/mTOR, and ERK/MAPK in the regulation of OPC differentiation and myelination both during development and in remyelination. Potential points of crosstalk between the three pathways and important areas for future research are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 2×
“AKT/mTOR Signaling Pathway AKT, also known as protein kinase B, is a serine/threonine kinase that regulates many intracellular molecules involved in basic processes including cell growth, proliferation, and survival (Dudek et al., 1997; Franke et al., 1997; Kennedy et al., 1997).”
BackgroundRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 2×
“…critical to clearly understand the cellular and molecular mechanisms that regulate myelination in order to develop novel therapies to target remyelination (Fancy et al., 2011a; Franklin, 2002; Franklin and Ffrench-Constant, 2008; Kotter et al., 2011; Miller and Bai, 2007; Miron et al., 2011).”
BackgroundDifferential regulation and properties of MAPKs
Raman, M., Chen, W., & Cobb, M. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210392 · Cited by 1,430 · cited 10×
“This study went on to show that ERK2 influences the rate of remyelination at least in part by controlling the translation of MBP. Future studies are necessary to elucidate additional molecular mechanisms and downstream targets of this pathway in order to accelerate the development of therapeutics aimed to enhance remy…”
BackgroundInfluentialPhosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 1×
“In tuberous sclerosis, a tumor syndrome caused by mutations in TSC1 or TSC2 genes, both ERK1/2 and AKT are thought to contribute to disease progression since they can each independently phosphorylate and inactivate TSC2 at distinct residues, resulting in the activation of mTORC1 (Ma et al., 2005).”
BackgroundPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling
Young, K. M., Psachoulia, K., Tripathi, R. B., Dunn, S.-J., Cossell, L., Attwell, D., Tohyama, K., & Richardson, W. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.006 · Cited by 919 · cited 1×
“The dynamic nature of myelin sheaths throughout the adult CNS has been supported by recent studies that demonstrate the continued generation of myelin throughout life (Young et al., 2013).”
BackgroundBace1 modulates myelination in the central and peripheral nervous system
Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006) · Nature Neuroscience · doi:10.1038/nn1797 · Cited by 608 · cited 3×
“BACE-1 is an enzyme that cleaves neuregulin-1 type III (NRG1-III) and is an important upstream enzyme that activates AKT signaling (Hu et al., 2006).”
BackgroundErk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597 · cited 1×
“In cancer cells, ERK1/2 phosphorylates and inactivates GSK3β leading to the up-regulation of β-catenin (Ding et al., 2005; McCubrey et al., 2014).”
BackgroundHDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X.-H., Bu, H., Hu, T., Taketo, M. M., van Es, J. H., Clevers, H., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2333 · Cited by 559 · cited 6×
“The TCF/LEF family consists of four members in mammals, although Tcf7l2 (also known as Tcf4) is most highly expressed by OLs (Fancy et al., 2009; Fu et al., 2009; Fu et al., 2012; Lang et al., 2013; Lurbke et al., 2013; Ye et al., 2009).”
BackgroundInfluentialCross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Aksamitiene, E., Kiyatkin, A., & Kholodenko, B. N. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110609 · Cited by 479 · cited 1×
“Outside of the field of myelination, particularly in the field of cancer research, ERK and AKT pathways are thought to be part of a complex signaling network with multiple points of crosstalk (Aksamitiene et al., 2012; Wood et al., 2013).”
BackgroundMazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456 · cited 1×
“Erk1 knockout mice are viable (Mazzucchelli et al., 2002), while the Erk2 knock out mice die during embryogenesis (Hatano et al., 2003; Saba-El-Leil et al., 2003; Yao et al., 2003) suggesting that these two structurally similar proteins may have distinct roles.”
BackgroundDrug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis
Kang, P., Lee, H. K., Glasgow, S. M., Finley, M., Donti, T., Gaber, Z. B., Graham, B. H., Foster, A. E., Novitch, B. G., Gronostajski, R. M., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.01.024 · Cited by 373
An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development
Saba‐El‐Leil, M. K., Vella, F. D. J., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S., & Meloche, S. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor939 · Cited by 366 · cited 2×
“, 2002), while the Erk2 knock out mice die during embryogenesis (Hatano et al., 2003; Saba-El-Leil et al., 2003; Yao et al., 2003) suggesting that these two structurally similar proteins may have distinct roles.”
BackgroundAxin2 as regulatory and therapeutic target in newborn brain injury and remyelination
Fancy, S. P. J., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini, S. E., Bruce, C. C., Otero, J. J., Huang, E. J., Nusse, R., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2855 · Cited by 349 · cited 4×
“…critical to clearly understand the cellular and molecular mechanisms that regulate myelination in order to develop novel therapies to target remyelination (Fancy et al., 2011a; Franklin, 2002; Franklin and Ffrench-Constant, 2008; Kotter et al., 2011; Miller and Bai, 2007; Miron et al., 2011).”
BackgroundInfluentialExtracellular signal-regulated kinase 2 is necessary for mesoderm differentiation
Yao, Y., Li, W., Wu, J., Germann, U. A., Su, M. S. S., Kuida, K., & Boucher, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134254100 · Cited by 323 · cited 2×
“, 2002), while the Erk2 knock out mice die during embryogenesis (Hatano et al., 2003; Saba-El-Leil et al., 2003; Yao et al., 2003) suggesting that these two structurally similar proteins may have distinct roles.”
BackgroundEssential role for ERK2 mitogen‐activated protein kinase in placental development
Hatano, N., Mori, Y., Oh‐hora, M., Kosugi, A., Fujikawa, T., Nakai, N., Niwa, H., Miyazaki, J., Hamaoka, T., & Ogata, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00680.x · Cited by 296
Tyler, W. A., Gangoli, N., Gokina, P., Kim, H. A., Covey, M., Levison, S. W., & Wood, T. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0234-09.2009 · Cited by 263 · cited 12×
“The TCF/LEF family consists of four members in mammals, although Tcf7l2 (also known as Tcf4) is most highly expressed by OLs (Fancy et al., 2009; Fu et al., 2009; Fu et al., 2012; Lang et al., 2013; Lurbke et al., 2013; Ye et al., 2009).”
BackgroundResultInfluentialOrtega, F., Gascón, S., Masserdotti, G., Deshpande, A., Simon, C., Fischer, J., Dimou, L., Chichung Lie, D., Schroeder, T., & Berninger, B. (2013) · Nature Cell Biology · doi:10.1038/ncb2736 · Cited by 247 · cited 1×
“Several studies have demonstrated that addition of extracellular Wnt molecules can increase OPC proliferation and differentiation in culture (Kalani et al., 2008; Ortega et al., 2013; Tawk et al., 2011).”
BackgroundPathophysiology of glia in perinatal white matter injury
Back, S. A., & Rosenberg, P. A. (2014) · Glia · doi:10.1002/glia.22658 · Cited by 202
Pattern of remyelination in the CNS
BLAKEMORE, W. F. (1974) · Nature · doi:10.1038/249577a0 · Cited by 182
The polarity protein Scribble regulates myelination and remyelination in the central nervous system
Jarjour, A. A., Boyd, A., Dow, L. E., Holloway, R. K., Goebbels, S., Humbert, P. O., Williams, A., & ffrench-Constant, C. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002107 · Cited by 39
Cited by
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Oligodendroglia: metabolic supporters of neurons
Philips, T., & Rothstein, J. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90610 · Cited by 342
Yan, Z., Gibson, S. A., Buckley, J. A., Qin, H., & Benveniste, E. N. (2018) · Clinical Immunology · doi:10.1016/j.clim.2016.09.014 · Cited by 318
Molecular Control of Oligodendrocyte Development
Elbaz, B., & Popko, B. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.01.002 · Cited by 293
Autophagy is essential for oligodendrocyte differentiation, survival, and proper myelination
Bankston, A. N., Forston, M. D., Howard, R. M., Andres, K. R., Smith, A. E., Ohri, S. S., Bates, M. L., Bunge, M. B., & Whittemore, S. R. (2019) · Glia · doi:10.1002/glia.23646 · Cited by 112
Metadata
- Authors
- Gaesser, J. M., & Fyffe-Maricich, S. L.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 283
- Issue
- Pt B
- Pages
- 501-511
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2292591575
- Cited by
- 210
- References
- 25
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.